Alia therapeutics
Cell & Gene Therapy
Facts
as of Nov 18, 2026Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
- Headquarters
- Milan, Italy
- Employees
- 11-50estimated range
- Website
- aliatherapeutics.com
These are the key facts about Alia therapeutics on Alion as of Nov 18, 2026. Alia therapeutics is headquartered in Milan, Italy. The latest round is Seed of $4.8M, announced in 2023.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Milan Italy | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$4.8MTotal raised
$350kPublic grants2 public grants
GrantLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
Sources: funding announcements, grant and company registers
Money
Alia therapeutics has $4.8M paid in by investors, lenders and donors.
$4.8MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
$156kPaid
$195kPaid
$4.8MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Owners & entities
Sources name Sofinnova Partners among the owners or investors of Alia therapeutics.
Named investors, no share stated1
Holders and shares as each register or filing states them.
Public record
Alia therapeutics: EUR 0–10,000 of EU lobbying in 2024.
Influence
EU lobbying, declared
EUR 0–10,000
Patents
Published US applications
3
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
Milestones
Each milestone is dated by its source: registers, filings, the press
